CENTER ID: | NafoA.18809.a |
ORGANISM: | Naegleria fowleri ATCC 30863 |
ASSOCIATED DISEASE: | |
CURRENT STATUS: | purified |
COMMUNITY REQUEST: | True |
NIH RISK GROUP: | 2 |
SELECT AGENT: | False |
NIH PRIORITY pathogens category: |
IIB |
CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
---|---|---|---|---|---|
NafoA.18809.a.B2.GE41829 | C-term sim to SmHMGR cat domain | 55 | 483 | ||
NafoA.18809.a.B3.GE41830 | XtalPred shorter C-term domain | 98 | 483 |
CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
---|---|---|---|---|---|
NafoA.18809.a.B2.PW38407 | C-term sim to SmHMGR cat domain | 55 | 483 |
RESOURCE | REFERENCE ID |
---|---|
EuPathDB: | AmoebaDB:NF0036310 |
HARVESTED ON: | 8/7/2017 |
SEQUENCED ON: | 9/20/2017 |
EXPECTED MW: | 47kDa |
OBSERVED MW: | 47kDa |
ANTIBIOTIC MARKER: | ampicillin |
COUNT OF EXPRESSION COLONIES: | Good (10-50) |
TOTAL EXPRESSION LEVEL: | Moderate Expression |
SOLUBLE EXPRESSION LEVEL | Moderate Expression |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
SEQUENCING RESULT: | |
PERCENT IDENTITY: | 99 |
PERCENT COVERAGE: | 100 |
HARVESTED ON: | 8/7/2017 |
SEQUENCED ON: | 9/20/2017 |
EXPECTED MW: | 42kDa |
OBSERVED MW: | 42kDa |
ANTIBIOTIC MARKER: | ampicillin |
COUNT OF EXPRESSION COLONIES: | Good (10-50) |
TOTAL EXPRESSION LEVEL: | Moderate Expression |
SOLUBLE EXPRESSION LEVEL | Moderate Expression |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
SEQUENCING RESULT: | |
PERCENT IDENTITY: | 99 |
PERCENT COVERAGE: | 100 |
PURIFICATION DATe: | 12/12/2017 |
CONCENTRATION: | 25.03mg/ml |
OBSERVED MW: | 47kDa |
EXPRESSION LEVEL: | High Expression |
PROTEIN PURIFICATION BUFFER: | 25 mM HEPES pH 7.0, 500 mM NaCl, 5% Glycerol , 2 mM DTT, 0.025% Azide |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
VIAL COUNT (approx.): | 3 |
VIAL VOLUME: | 200µl |
PERCENT IDENTITY: | 99 |
PERCENT COVERAGE: | 100 |